Loading clinical trials...
Loading clinical trials...
Study 07-PIR-02 is a Phase 2 study designed to evaluate the safety and efficacy of NKTR-102 (PEG-irinotecan) for the treatment of patients with colorectal cancer (CRC). The study is comprised of two s...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Nektar Therapeutics
NCT07003542 · Glioblastoma, Brain Tumor
NCT07060989 · Advanced Solid Tumors
NCT06659341 · Advanced Solid Tumors Harboring KRAS G12C Mutation
NCT06813079 · Pancreatic Ductal Carcinoma, Advanced Cancer, and more
NCT05533697 · Advanced Solid Tumors
Investigator Site - Scottsdale
Scottsdale, Arizona
Investigator Site - Louisville
Louisville, Kentucky
Investigator Site - Dallas
Dallas, Texas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions